Diabetic nephropathy

M. E. Molitch; R. A. DeFronzo; M. J. Franz; W. F. Keane; C. E. Mogensen; H. H. Parving; M. W. Steffes

doi:10.2337/diacare.21.1.s50

Diabetic nephropathy

M. E. Molitch, R. A. DeFronzo, M. J. Franz, W. F. Keane, C. E. Mogensen, H. H. Parving, M. W. Steffes

Producción científica: Review article › revisión exhaustiva

62 Citas (Scopus)

Resumen

Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of AGE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

Idioma original	English (US)
Páginas (desde-hasta)	S50-S53
Publicación	Diabetes care
Volumen	21
N.º	SUPPL. 1
DOI	https://doi.org/10.2337/diacare.21.1.s50
Estado	Published - ene 1998
Publicado de forma externa	Sí

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

Acceder al documento

10.2337/diacare.21.1.s50

Otros archivos y enlaces

Citar esto

@article{8a63cec2b89d4a85872b0ab0db418b73,

title = "Diabetic nephropathy",

abstract = "Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of AGE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.",

author = "Molitch, {M. E.} and DeFronzo, {R. A.} and Franz, {M. J.} and Keane, {W. F.} and Mogensen, {C. E.} and Parving, {H. H.} and Steffes, {M. W.}",

year = "1998",

month = jan,

doi = "10.2337/diacare.21.1.s50",

language = "English (US)",

volume = "21",

pages = "S50--S53",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Diabetic nephropathy

AU - Molitch, M. E.

AU - DeFronzo, R. A.

AU - Franz, M. J.

AU - Keane, W. F.

AU - Mogensen, C. E.

AU - Parving, H. H.

AU - Steffes, M. W.

PY - 1998/1

Y1 - 1998/1

N2 - Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of AGE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

AB - Annual screening for microalbuminuria will allow the identification of patients with nephropathy at a point very early in its course. Improving glycemic control, aggressive antihypertensive treatment, and the use of AGE inhibitors will slow the rate of progression of nephropathy. In addition, protein restriction and other treatment modalities such as phosphate lowering may have benefits in selected patients.

UR - http://www.scopus.com/inward/record.url?scp=0031985190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031985190&partnerID=8YFLogxK

U2 - 10.2337/diacare.21.1.s50

DO - 10.2337/diacare.21.1.s50

M3 - Review article

AN - SCOPUS:0031985190

SN - 0149-5992

VL - 21

SP - S50-S53

JO - Diabetes care

JF - Diabetes care

IS - SUPPL. 1

ER -

Diabetic nephropathy

Resumen

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto